Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|
Operating cash flow (Indirect Method) | |||
Cash from operating activities | -20.64%3.07B | 6.01%3.86B | 3.64B |
Net profit before non-cash adjustment | -9.41%4.31B | 123.99%4.76B | --2.13B |
Total adjustment of non-cash items | -96.97%25M | -36.29%825M | --1.3B |
-Depreciation and amortization | -0.33%893M | 9.67%896M | --817M |
-Disposal profit | -14.29%18M | 133.87%21M | ---62M |
-Other non-cash items | -863.04%-886M | -117.04%-92M | --540M |
Changes in working capital | 26.04%-1.28B | -873.09%-1.72B | --223M |
-Change in receivables | -9.41%-2.08B | -981.25%-1.9B | ---176M |
-Change in inventory | -137.26%-1.01B | 67.00%-424M | ---1.29B |
-Change in payables | 59.54%1.31B | 150.91%823M | --328M |
-Provision for loans, leases and other losses | 80.31%229M | 18.69%127M | --107M |
-Changes in other current assets | 178.10%271M | -127.78%-347M | --1.25B |
Dividends paid (cash flow from operating activities) | |||
Dividends received (cash flow from operating activities) | |||
Interest paid (cash flow from operating activities) | 2.44%-40M | -46.43%-41M | -28M |
Interest received (cash flow from operating activities) | 56.60%83M | 178.95%53M | 19M |
Tax refund paid | -111.05%-1.11B | -88.17%-525M | -279M |
Other operating cash inflow (outflow) | 0 | 0 | 41M |
Operating cash flow | -40.28%2B | -1.38%3.35B | --3.4B |
Investing cash flow | |||
Net PPE purchase and sale | -323.42%-2.41B | -7.98%-568M | ---526M |
Net intangibles purchase and sale | -41.67%-17M | 96.00%-12M | ---300M |
Net investment product transactions | --71M | --0 | --1.1B |
Net changes in other investments | 173.33%11M | -87.50%-15M | ---8M |
Investing cash flow | -293.28%-2.34B | -322.01%-595M | --268M |
Financing cash flow | |||
Net issuance payments of debt | -1,404.30%-2.8B | 77.86%-186M | ---840M |
Net common stock issuance | 928.82%4.72B | ---569M | --0 |
Increase or decrease of lease financing | -26.42%-67M | -112.00%-53M | ---25M |
Issuance fees | ---40M | --0 | ---- |
Cash dividends paid | 10.00%-9M | 0.00%-10M | ---10M |
Net other fund-raising expenses | ---1M | ---- | ---1M |
Financing cash flow | 320.17%1.8B | 6.62%-818M | ---876M |
Net cash flow | |||
Beginning cash position | 28.82%9.52B | 69.61%7.39B | --4.36B |
Current changes in cash | -24.54%1.46B | -30.56%1.94B | --2.79B |
Effect of exchange rate changes | 126.94%438M | -20.90%193M | --244M |
Cash adjustments other than cash changes | --1M | ---- | ---- |
End cash Position | 19.96%11.42B | 28.82%9.52B | --7.39B |
Free cash flow | -115.24%-422M | 7.87%2.77B | --2.57B |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |